Kodiak Sciences Inc. (KOD) short interest & options flow
NASDAQKodiak Sciences is a clinical-stage biotech developing treatments for blinding eye diseases, and after a 182% rally over the past month it now finds itself in an unusual position: short sellers are leaving, an activist is consolidating, and options traders have turned notably bullish, all ahead of a November 12 earnings print. The short side tells a clear retreat story. Short…
KOD put/call ratio spikes to 1.31, highest in 52 weeks—4.4 standard deviations above 20-day mean of 0.51, signaling extreme options market fear despite modest short interest declines.
- Market cap
- $6.78B
- Next earnings
- 12 Nov 2026
Key data as of 11 Nov 2026

KOD news and analysis
RSSNo long-form analysis yet for KOD. Pulse alerts and the live data picture are available on ORTEX.
Open KOD on ORTEX →Want the live picture for KOD?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for KOD — free to start on ORTEX.
Sign up for free →Open KOD on ORTEX